Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Kiora Pharmaceuticals (KPRX) Leases (2019 - 2025)

Kiora Pharmaceuticals' Leases history spans 7 years, with the latest figure at $285827.0 for Q4 2025.

  • For Q4 2025, Leases rose 399.96% year-over-year to $285827.0; the TTM value through Dec 2025 reached $285827.0, up 399.96%, while the annual FY2025 figure was $285827.0, 399.96% up from the prior year.
  • Leases reached $285827.0 in Q4 2025 per KPRX's latest filing, down from $318036.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $349017.0 in Q2 2025 to a low of $18725.0 in Q3 2023.
  • Average Leases over 5 years is $166953.1, with a median of $152083.0 recorded in 2025.
  • Peak YoY movement for Leases: crashed 87.3% in 2023, then soared 399.96% in 2025.
  • A 5-year view of Leases shows it stood at $209411.0 in 2021, then dropped by 29.59% to $147456.0 in 2022, then decreased by 27.51% to $106890.0 in 2023, then plummeted by 46.52% to $57170.0 in 2024, then surged by 399.96% to $285827.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Leases are $285827.0 (Q4 2025), $318036.0 (Q3 2025), and $349017.0 (Q2 2025).